Parallax Volatility Advisers, L.P. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,008,450
-68.1%
45,000
-45.6%
0.00%
-60.0%
Q4 2022$3,159,10282,764
+1034450.0%
0.01%
Q4 2018$0
-100.0%
8
-93.2%
0.00%
Q3 2018$5,000
-99.8%
117
-99.9%
0.00%
-100.0%
Q2 2018$2,867,000
-39.5%
85,000
-51.4%
0.00%
-33.3%
Q1 2018$4,736,000
-80.3%
175,000
-87.9%
0.01%
-81.2%
Q4 2017$24,025,000
+240150.0%
1,440,384
+254384.8%
0.03%
Q2 2017$10,000
-94.8%
566
-98.1%
0.00%
Q1 2016$193,000
-91.5%
30,000
-57.1%
0.00%
-100.0%
Q4 2015$2,268,00070,0000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders